Key result
Intravenous Albunex was well tolerated with no serious side effects, achieving right and left ventricular cavity opacification ≥+2 in 88% and 63% of injections, respectively.
Why the study?
Does intravenous sonicated albumin microspheres safely provide ventricular cavity opacification during echocardiography?
Does intravenous sonicated albumin microspheres safely provide ventricular cavity opacification during echocardiography?
Answers are grounded in this paper and cite their sources.
Intravenous sonicated albumin microspheres safely and effectively provide right and left ventricular cavity opacification during echocardiography.
Myocardial contrast echocardiography has been found to be a safe and useful technique for evaluating relative changes in myocardial perfusion and delineating areas at risk. Although earlier contrast agents required direct delivery into the coronary arteries or aortic root, a new echocardiographic contrast agent, sonicated albumin microspheres (Albunex), has been found to cross the pulmonary circulation in experimental models. To determine the safety and preliminary efficacy of intravenous injections of Albunex in humans, 71 patients at three independent medical institutions underwent two-dimensional echocardiographic examination before, during and after the administration of three intravenous doses of Albunex, ranging from 0.01 to 0.12 ml/kg body weight. All patients provided a complete history and underwent physical and neurologic examination and laboratory and electrocardiographic evaluation before the injections; all evaluations (except for the history) were repeated at 2 h and 3 days after the injections of Albunex. The efficacy of the injections was qualitatively assessed by two independent blinded observers using a grading system of 0 to +3, with 0 indicating an absence of contrast effect and +3 indicating full opacification of the cavities examined. All injections were well tolerated and no serious side effects were noted in any of the patients. Irrespective of dose group, a cavity opacification greater than or equal to +2 was seen in the right ventricle in 212 (88%) of 240 injections and in the left ventricle in 151 (63%) of 240 injections as judged by the independent observers. The degree of ventricular cavity opacification appeared to be dose and concentration related.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Feinstein et al. (1990) studied this question. Albunex (sonicated albumin microspheres) was evaluated on Cavity opacification greater than or equal to +2 in the right ventricle. Intravenous Albunex was well tolerated with no serious side effects, achieving right and left ventricular cavity opacification ≥+2 in 88% and 63% of injections, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: